Adicet Bio, Inc. financial data

Symbol
ACET on Nasdaq
Location
131 Dartmouth Street, 3 Rd Floor, Boston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.05K % -1.92%
Debt-to-equity 16.6 % -3.83%
Return On Equity -59.1 % +8.89%
Return On Assets -50.7 % +8.37%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 82.7M shares +0.65%
Common Stock, Shares, Outstanding 82.7M shares +0.66%
Entity Public Float 84.4M USD +10%
Common Stock, Value, Issued 8K USD 0%
Weighted Average Number of Shares Outstanding, Basic 91.1M shares +15.2%
Weighted Average Number of Shares Outstanding, Diluted 91.1M shares +15.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 98.2M USD -4.79%
General and Administrative Expense 28.4M USD +5.38%
Operating Income (Loss) -127M USD +15.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -117M USD +16.1%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -117M USD +16.1%
Earnings Per Share, Basic -1 USD/shares +56.1%
Earnings Per Share, Diluted -1 USD/shares +56.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 28.1M USD -82.4%
Other Assets, Current 478K USD -22%
Assets, Current 154M USD -38.7%
Property, Plant and Equipment, Net 21.1M USD -16.9%
Operating Lease, Right-of-Use Asset 13.4M USD -19.6%
Goodwill 0 USD -100%
Other Assets, Noncurrent 314K USD -54.6%
Assets 191M USD -34.7%
Accounts Payable, Current 4.4M USD +73.2%
Employee-related Liabilities, Current 4.89M USD +18.7%
Liabilities, Current 16.4M USD -5.81%
Operating Lease, Liability, Noncurrent 13.3M USD -20.7%
Other Liabilities, Noncurrent 116K USD 0%
Liabilities 29.8M USD -13%
Accumulated Other Comprehensive Income (Loss), Net of Tax -9K USD
Retained Earnings (Accumulated Deficit) -526M USD -28.7%
Stockholders' Equity Attributable to Parent 161M USD -37.6%
Liabilities and Equity 191M USD -34.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -25.4M USD -11.2%
Net Cash Provided by (Used in) Financing Activities -104K USD -100%
Net Cash Provided by (Used in) Investing Activities -2.86M USD -1097%
Common Stock, Shares Authorized 300M shares +100%
Common Stock, Shares, Issued 82.7M shares +0.66%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -28.4M USD -132%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 31M USD -87.5%
Deferred Tax Assets, Valuation Allowance 119M USD +20.4%
Deferred Tax Assets, Gross 122M USD +19%
Operating Lease, Liability 16.2M USD -18.9%
Depreciation 1.68M USD +1.76%
Payments to Acquire Property, Plant, and Equipment 1.49M USD +524%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -28.2M USD -0.8%
Lessee, Operating Lease, Liability, to be Paid 19.5M USD -20.6%
Property, Plant and Equipment, Gross 44.1M USD +5.25%
Operating Lease, Liability, Current 2.98M USD -10.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.24M USD -27.9%
Deferred Tax Assets, Operating Loss Carryforwards 74.8M USD +14.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 26.4M USD +42.8%
Operating Lease, Payments 900K USD -40%
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments, Due in Two Years 4.66M USD +4.76%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 5.02M USD +16%
Deferred Tax Assets, Net of Valuation Allowance 3M USD -18.3%
Share-based Payment Arrangement, Expense 19.7M USD -6.8%
Operating Leases, Future Minimum Payments, Due in Three Years 4.01M USD -2.12%
Operating Leases, Future Minimum Payments Due 27M USD -2.15%
Interest Expense 2K USD -75%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%